Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Pozycja w akcjach #40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Cena akcji
$152.40
Kapitalizacja rynkowa
$376.40B
Zmiana (1 dzień)
12.48%
Zmiana (1 rok)
79.44%
Kraj
US
Handel Merck & Co., Inc. (MRK)

Kategoria

Marża operacyjna dla Merck & Co., Inc. (MRK)
Marża operacyjna na dzień August 2026 TTM: 16.65%
Według najnowszych raportów finansowych i ceny akcji Merck & Co., Inc., bieżąca marża operacyjna (TTM) wynosi 16.65%. Na koniec 2024 wynosiła 31.51%.
Historia marży operacyjnej dla Merck & Co., Inc. od 2000 do 2026
Marża operacyjna na koniec każdego roku
Rok Marża operacyjna Zmień
2026 (TTM) 16.65% -59.58%
2025 41.19% 30.72%
2024 31.51% 541.75%
2023 4.91% -84.08%
2022 30.84% 13.80%
2021 27.10% 102.84%
2020 13.36% -34.06%
2019 20.26% -4.07%
2018 21.12% 24.68%
2017 16.94% 22.66%
2016 13.81% -27.73%
2015 19.11% 20.80%
2014 15.82% -9.13%
2013 17.41% -16.70%
2012 20.90% 11.88%
2011 18.68% 155.89%
2010 7.30% -50.20%
2009 14.66% -42.53%
2008 25.51% 9.86%
2007 23.22% 42.54%
2006 16.29% -38.81%
2005 26.62% -9.52%
2004 29.42% -22.80%
2003 38.11% -10.08%
2002 42.38% -3.18%
2001 43.77% 94.36%
2000 22.52% 0.00%
Marża operacyjna dla podobnych firm lub konkurentów
Firma Marża operacyjna Różnica w marży operacyjnej Kraj
43.92% -97.36%
US
26.81% -98.39%
US
29.32% -98.24%
US
26.59% -98.40%
CH
31.24% -98.12%
CH
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.